Live feed08:30:00·9mPRReleasevia QuantisnowQuoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of QRX003 in Peeling Skin SyndromeByQuantisnow·Wall Street's wire, on your screen.QNRX· Quoin Pharmaceuticals Ltd.Health Care
